References

Cancer statistics, 2020

2020 · External reference

10.1158/0008-5472.can-14-0155

10.1158/0008-5472.can-14-0155 · External reference

Metabolomics and biomarker discovery

10.1007/978-3-030-15950-4_37 · 2019 · External reference

Pancreatic cancer diagnosis and management: has the time come to prick the bubble?

10.3389/fendo.2018.00779 · 2019 · External reference

10.1056/nejmra0901557

10.1056/nejmra0901557 · External reference

10.1093/annonc/mdp332

10.1093/annonc/mdp332 · External reference

Clinical usefulness of carbohydrate antigen 19–9 as a screening test for pancreatic cancer in an asymptomatic population

10.1111/j.1440-1746.2004.03219.x · 2004 · External reference

10.1146/annurev.genom.2.1.343

10.1146/annurev.genom.2.1.343 · External reference

10.1038/s41576-020-0212-5

10.1038/s41576-020-0212-5 · External reference

10.1097/mpa.0000000000001324

10.1097/mpa.0000000000001324 · External reference

10.1007/s10689-014-9755-y

10.1007/s10689-014-9755-y · External reference

Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer

10.1001/jama.2018.6228 · 2018 · External reference

Early detection of pancreatic cancer: where are we now and where are we going?: early detection of pancreatic cancer

10.1002/ijc.30670 · 2017 · External reference

10.1080/14789450.2019.1559062

10.1080/14789450.2019.1559062 · External reference

10.1053/j.gastro.2013.12.007

10.1053/j.gastro.2013.12.007 · External reference

Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization

2016 · External reference

10.1007/s13277-015-4589-2

10.1007/s13277-015-4589-2 · External reference

Live single cell mass spectrometry reveals cancer‐specific metabolic profiles of circulating tumor cells

10.1111/cas.13915 · 2019 · External reference

10.1016/j.trsl.2017.04.002

10.1016/j.trsl.2017.04.002 · External reference

10.1038/s41576-018-0071-5

10.1038/s41576-018-0071-5 · External reference

10.1126/scitranslmed.3007094

10.1126/scitranslmed.3007094 · External reference

10.1073/pnas.1704961114

10.1073/pnas.1704961114 · External reference

10.1053/j.gastro.2016.04.034

10.1053/j.gastro.2016.04.034 · External reference

10.1200/jco.2017.76.8671

10.1200/jco.2017.76.8671 · External reference

10.3390/epigenomes3010005

10.3390/epigenomes3010005 · External reference

10.1158/1078-0432.ccr-12-3224

10.1158/1078-0432.ccr-12-3224 · External reference

Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood

2019 · External reference

10.1038/nrg2484

10.1038/nrg2484 · External reference

10.1056/nejmra042342

10.1056/nejmra042342 · External reference

10.1016/j.pcad.2012.06.003

10.1016/j.pcad.2012.06.003 · External reference

Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer

2015 · External reference

Noncoding RNA: RNA regulatory networks in cancer

2018 · External reference

Circulating microRNAs in pancreatic juice as candidate biomarkers of pancreatic cancer

10.7150/jca.10094 · 2014 · External reference

MicroRNAs for detection of pancreatic neoplasia: biomarker discovery by next-generation sequencing and validation in 2 independent cohorts

10.1097/sla.0000000000001809 · 2017 · External reference

Circulating lncRNA ABHD11-AS1 serves as a biomarker for early pancreatic cancer diagnosis

10.7150/jca.32052 · 2019 · External reference

10.18632/oncotarget.10891

10.18632/oncotarget.10891 · External reference

10.1158/1078-0432.ccr-18-1955

10.1158/1078-0432.ccr-18-1955 · External reference

10.1002/jimd.12130

10.1002/jimd.12130 · External reference

Proteomics approach and techniques in identification of reliable biomarkers for diseases

10.1016/j.sjbs.2020.01.020 · 2020 · External reference

Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers

10.1074/mcp.m111.008599 · 2011 · External reference

Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9

10.1186/1471-2407-13-404 · 2013 · External reference

10.1038/bjc.2016.295

10.1038/bjc.2016.295 · External reference

Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profiling: a novel biomarker for pancreatic ductal adenocarcinoma

10.1002/ijc.30227 · 2016 · External reference

Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models

10.1038/bjc.2015.370 · 2015 · External reference

Identification of serum biomarker panels for the early detection of pancreatic cancer

10.1158/1055-9965.epi-18-0483 · 2019 · External reference

10.1093/jnci/djw266

10.1093/jnci/djw266 · External reference

A combination of MUC5AC and CA19-9 improves the diagnosis of pancreatic cancer: a multicenter study:

10.1038/ajg.2016.482 · 2017 · External reference

10.1126/scitranslmed.aah5583

10.1126/scitranslmed.aah5583 · External reference

Metabonomics

10.1038/4551054a · 2008 · External reference

Identification of highly sensitive biomarkers that can aid the early detection of pancreatic cancer using GC/MS/MS-based targeted metabolomics

10.1016/j.cca.2017.02.011 · 2017 · External reference

Pancreatic cancer screening using a multiplatform human serum metabolomics system

10.2217/bmm-2016-0020 · 2016 · External reference

A novel serum metabolomics-based diagnostic approach to pancreatic cancer

10.1158/1055-9965.epi-12-1033 · 2013 · External reference

10.18632/oncotarget.25212

10.18632/oncotarget.25212 · External reference

The metabolic time line of pancreatic cancer: Opportunities to improve early detection of adenocarcinoma

10.1016/j.amjsurg.2019.08.015 · 2019 · External reference

Challenges and opportunities in cancer metabolomics

10.1002/pmic.201900042 · 2019 · External reference

Plasma interleukin-11 (IL-11) levels have diagnostic and prognostic roles in patients with pancreatic cancer

10.1007/s13277-014-2459-y · 2014 · External reference

Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma

10.1186/1471-2407-14-578 · 2014 · External reference

10.1021/pr5002719

10.1021/pr5002719 · External reference

Q & A: what are exosomes, exactly?

10.1186/s12915-016-0268-z · 2016 · External reference

10.1038/nature14581

10.1038/nature14581 · External reference

10.1021/acsnano.7b08199

10.1021/acsnano.7b08199 · External reference

Label-free characterization of exosome via surface enhanced Raman spectroscopy for the early detection of pancreatic cancer

10.1016/j.nano.2018.11.008 · 2019 · External reference

Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer

10.1007/s11306-019-1550-1 · 2019 · External reference

Highly accurate identification of cystic precursor lesions of pancreatic cancer through targeted mass spectrometry: a phase IIc diagnostic study

10.1200/jco.2017.73.7288 · 2018 · External reference

10.1002/cam4.2340

10.1002/cam4.2340 · External reference

10.1097/mpa.0000000000000931

10.1097/mpa.0000000000000931 · External reference

10.1002/pmic.201400476

10.1002/pmic.201400476 · External reference

Bile proteomics for differentiation of malignant from benign biliary strictures: a pilot study

10.1093/gastro/gou066 · 2015 · External reference

Levels of soluble LR11/SorLA are highly increased in the bile of patients with biliary tract and pancreatic cancers

10.1016/j.cca.2016.04.010 · 2016 · External reference

10.1158/1078-0432.ccr-14-2467

10.1158/1078-0432.ccr-14-2467 · External reference

Neutrophil Gelatinase-Associated Lipocalin (NGAL) concentration in urine is superior to CA19-9 and Ca 125 in differentiation of pancreatic mass: Preliminary report

10.3233/cbm-160595 · 2016 · External reference

10.1371/journal.pone.0161009

10.1371/journal.pone.0161009 · External reference

Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach

10.18632/oncotarget.17463 · 2017 · External reference

Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel

10.18632/oncotarget.21861 · 2017 · External reference

A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline

10.1038/bjc.2017.365 · 2017 · External reference

10.1093/jnci/djw341

10.1093/jnci/djw341 · External reference

A panel of three biomarkers identified by iTRAQ for the early diagnosis of pancreatic cancer

10.1002/prca.201800195 · 2019 · External reference

10.1016/j.ebiom.2019.03.056

10.1016/j.ebiom.2019.03.056 · External reference

10.1093/bib/bbw114

10.1093/bib/bbw114 · External reference

10.1016/j.ccell.2017.07.007

10.1016/j.ccell.2017.07.007 · External reference

Bioinformatics tools and workflow to select blood biomarkers for early cancer diagnosis: an application to pancreatic cancer

10.1002/pmic.201800489 · 2019 · External reference

10.3390/cancers11020155

10.3390/cancers11020155 · External reference

10.3389/fgene.2017.00084

10.3389/fgene.2017.00084 · External reference

10.1177/1177932219899051

10.1177/1177932219899051 · External reference

Benchmarks for the assessment of novel cardiovascular biomarkers

10.1161/circulationaha.106.683110 · 2007 · External reference